163 related articles for article (PubMed ID: 25368236)
1. Differential impact of tumor-infiltrating immune cells on basal and luminal cells: implications for tumor invasion and metastasis.
Song G; Hsiao H; Wang JL; Mannion C; Stojadinovic A; Avital I; Fu SW; Mason J; Chen W; Jewett A; Li H; Man YG
Anticancer Res; 2014 Nov; 34(11):6363-80. PubMed ID: 25368236
[TBL] [Abstract][Full Text] [Related]
2. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
Man YG; Gardner WA
Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
[TBL] [Abstract][Full Text] [Related]
3. Destructive impact of T-lymphocytes, NK and Mast cells on basal cell layers: implications for tumor invasion.
Yuan H; Hsiao YH; Zhang Y; Wang J; Yin C; Shen R; Su Y
BMC Cancer; 2013 May; 13():258. PubMed ID: 23705594
[TBL] [Abstract][Full Text] [Related]
4. Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion.
Man YG; Tai L; Barner R; Vang R; Saenger JS; Shekitka KM; Bratthauer GL; Wheeler DT; Liang CY; Vinh TN; Strauss BL
Breast Cancer Res; 2003; 5(6):R231-41. PubMed ID: 14580259
[TBL] [Abstract][Full Text] [Related]
5. Atypical E-cadherin expression in cell clusters overlying focally disrupted mammary myoepithelial cell layers: implications for tumor cell motility and invasion.
Zhang X; Hashemi SS; Yousefi M; Gao C; Sheng J; Ni J; Wang W; Mason J; Man YG
Pathol Res Pract; 2009; 205(6):375-85. PubMed ID: 19395181
[TBL] [Abstract][Full Text] [Related]
6. APRIL promotes breast tumor growth and metastasis and is associated with aggressive basal breast cancer.
García-Castro A; Zonca M; Florindo-Pinheiro D; Carvalho-Pinto CE; Cordero A; Gutiérrez del Fernando B; García-Grande A; Mañes S; Hahne M; González-Suárez E; Planelles L
Carcinogenesis; 2015 May; 36(5):574-84. PubMed ID: 25750171
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of chromogranin A, miR-146a, and miR-146b-5p in prostate structures with focally disrupted basal cell layers: an early sign of invasion and hormone-refractory cancer?
Man YG; Fu SW; Liu AJ; Stojadinovic A; Izadjoo MJ; Chen L; Gardner WA
Cancer Genomics Proteomics; 2011; 8(5):235-44. PubMed ID: 21980038
[TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating immune cells: triggers for tumor capsule disruption and tumor progression?
Jiang B; Mason J; Jewett A; Liu ML; Chen W; Qian J; Ding Y; Ding S; Ni M; Zhang X; Man YG
Int J Med Sci; 2013; 10(5):475-97. PubMed ID: 23532368
[TBL] [Abstract][Full Text] [Related]
9. The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance.
Di Carlo E; D'Antuono T; Pompa P; Giuliani R; Rosini S; Stuppia L; Musiani P; Sorrentino C
Clin Cancer Res; 2009 May; 15(9):2979-87. PubMed ID: 19366834
[TBL] [Abstract][Full Text] [Related]
10. Focal degeneration of aged or injured myoepithelial cells and the resultant auto-immunoreactions are trigger factors for breast tumor invasion.
Man YG
Med Hypotheses; 2007; 69(6):1340-57. PubMed ID: 17493765
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.
Merdad A; Karim S; Schulten HJ; Dallol A; Buhmeida A; Al-Thubaity F; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH
Anticancer Res; 2014 Mar; 34(3):1355-66. PubMed ID: 24596383
[TBL] [Abstract][Full Text] [Related]
12. A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion.
Man YG; Shen T; Weisz J; Berg PE; Schwartz AM; Mulshine JL; Sang QX; Nieburgs HE
Cancer Detect Prev; 2005; 29(4):323-31. PubMed ID: 16122886
[TBL] [Abstract][Full Text] [Related]
13. Hidden malignant cells within leukocyte aggregates: seeds for invasive and metastatic cancer?
Hsiao YH; Deng C; Mason JT; Chou MC; Man YG
Cancer Epidemiol; 2011 Oct; 35(5):475-9. PubMed ID: 21292584
[TBL] [Abstract][Full Text] [Related]
14. Aberrant c-erbB2 expression in cell clusters overlying focally disrupted breast myoepithelial cell layers: a trigger or sign for emergence of more aggressive cell clones?
Zhang X; Hashemi SS; Yousefi M; Ni J; Wang Q; Gao L; Gong P; Gao C; Sheng J; Mason J; Man YG
Int J Biol Sci; 2008 Aug; 4(5):259-69. PubMed ID: 18726004
[TBL] [Abstract][Full Text] [Related]
15. Leukocyte-mediated cell dissemination and metastasis: findings from multiple types of human tumors.
Man YG; Mason J; Harley R; Kim YH; Zhu K; Gardner WA
J Cell Biochem; 2011 Apr; 112(4):1154-67. PubMed ID: 21312236
[TBL] [Abstract][Full Text] [Related]
16. Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity.
Wang ZA; Mitrofanova A; Bergren SK; Abate-Shen C; Cardiff RD; Califano A; Shen MM
Nat Cell Biol; 2013 Mar; 15(3):274-83. PubMed ID: 23434823
[TBL] [Abstract][Full Text] [Related]
17. Bad seeds produce bad crops: a single stage-process of prostate tumor invasion.
Man YG; Gardner WA
Int J Biol Sci; 2008 Aug; 4(4):246-58. PubMed ID: 18725981
[TBL] [Abstract][Full Text] [Related]
18. BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition.
Coppola V; Musumeci M; Patrizii M; Cannistraci A; Addario A; Maugeri-Saccà M; Biffoni M; Francescangeli F; Cordenonsi M; Piccolo S; Memeo L; Pagliuca A; Muto G; Zeuner A; De Maria R; Bonci D
Oncogene; 2013 Apr; 32(14):1843-53. PubMed ID: 22614007
[TBL] [Abstract][Full Text] [Related]
19. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
20. Negligible nuclear FOXP3 expression in breast cancer epithelial cells compared with FOXP3-positive T cells.
Droeser RA; Obermann EC; Wolf AM; Wallner S; Wolf D; Tzankov A
Clin Breast Cancer; 2013 Aug; 13(4):264-70. PubMed ID: 23829892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
